ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Liu R

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6723-1856; OpenAlex author ID A5108054603. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2026: 1 paper

Papers 1

Efficacy and safety of surufatinib and sintilimab with or without chemotherapy for advanced high-grade neuroendocrine neoplasms and pancreatic cancer. Last author DOI 10.1038/s41698-026-01478-y ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhi Ji · 1 shared paper, 2026 · strength 0.33
- Paper Efficacy and safety of surufatinib and sintilimab with or without chemotherapy for advanced high-grade neuroendocrine n… DOI 10.1038/s41698-026-01478-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.